Literature DB >> 21887729

Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis.

Siew C Ng1, Kelvin K F Tsoi, Michael A Kamm, Bing Xia, Justin Wu, Francis K L Chan, Joseph J Y Sung.   

Abstract

BACKGROUND: Inflammatory bowel diseases (IBD) result from an interaction between genetic and environmental factors. Preliminary findings suggest that susceptibility genes differ between IBD patients in Asia and the West. We aimed to evaluate disease-predisposing genes in Asian IBD patients.
METHODS: A systematic review and meta-analysis were performed of published studies from 1950 to 2010 using keyword searches in MEDLINE, EMBASE, EBM Reviews, and BIOSIS Previews.
RESULTS: In all, 477 abstracts were identified and data extracted from 93 studies, comprising 17,976 IBD patients and 27,350 age- and sex-matched controls. Major nucleotide oligomerization domain (NOD)-2 variants in Western Crohn's disease (CD) patients were not associated with CD in Han Chinese, Japanese, South Korean, Indian, and Malaysian populations. New NOD2 mutations were, however, associated with CD in Malaysians (JW1), Han Chinese, and Indians (P268S). Autophagy-related protein 16-linked 1 (ATG16L1) was not associated with CD in East Asians (odds ratio [OR] 0.97; 95% confidence interval [CI] 0.84-1.13). Interleukin (IL)-23R was associated with CD in South Koreans (OR 1.8; 95% CI 1.16-2.82) and a single nucleotide polymorphism in IL-23R (Gly149Arg) was protective of CD in Han Chinese (OR 0.3; 95% CI 0.15-0.60). Tumor necrosis factor (TNF) superfamily gene-15 (SF15) polymorphisms were associated with CD (OR 2.68; 95% CI 1.86-3.86), while TNF-308 polymorphisms (OR 1.82; 95% CI 1.15-2.9), cytotoxic T lymphocyte antigen (CTLA)-4 (OR 2.75; 95% CI 1.22-6.22) and MICA allele (OR 2.41; 95% CI 1.89-3.07) were associated with ulcerative colitis in Asians.
CONCLUSIONS: Genetic mutations of IBD in Asians differ from Caucasians. New mutations and susceptibility genes identified in Asian IBD patients provide an opportunity to explore new disease-associated mechanisms in this population of rising incidence.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21887729     DOI: 10.1002/ibd.21845

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  71 in total

1.  IBD: Genetics of IBD in asian populations.

Authors:  Katherine Smith
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

Review 2.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

3.  Common NOD2 risk variants in African Americans with Crohn's disease are due exclusively to recent Caucasian admixture.

Authors:  Oloruntosin Adeyanju; David T Okou; Clifton Huang; Archana Kumar; Cary Sauer; Courtney Galloway; Mahadev Prasad; Jon Waters; David J Cutler; Michael E Zwick; Tanvi Dhere; Subra Kugathasan
Journal:  Inflamm Bowel Dis       Date:  2012-03-22       Impact factor: 5.325

4.  Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors.

Authors:  Sanjay S Shete; Maria E Suarez-Almazor; Noha Abdel-Wahab; Adi Diab; Robert K Yu; Andrew Futreal; Lindsey A Criswell; Jean H Tayar; Ramona Dadu; Vickie Shannon
Journal:  Cancer Immunol Immunother       Date:  2021-01-07       Impact factor: 6.968

5.  Inflammatory bowel disease in Asia.

Authors:  Siew C Ng
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-01

Review 6.  The use of prognostic factors in inflammatory bowel diseases.

Authors:  Thomas Billiet; Marc Ferrante; Gert Van Assche
Journal:  Curr Gastroenterol Rep       Date:  2014-11

7.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

8.  Immunochip analysis identification of 6 additional susceptibility loci for Crohn's disease in Koreans.

Authors:  Suk-Kyun Yang; Myunghee Hong; Hyunchul Choi; Wanting Zhao; Yusun Jung; Talin Haritunians; Byong Duk Ye; Kyung-Jo Kim; Sang Hyoung Park; Inchul Lee; Won Ho Kim; Jae Hee Cheon; Young-Ho Kim; Byung Ik Jang; Hyun-Soo Kim; Jai Hyun Choi; Ja Seol Koo; Ji Hyun Lee; Sung-Ae Jung; Hyoung Doo Shin; Daehee Kang; Hee-Shang Youn; Kent D Taylor; Jerome I Rotter; Jianjun Liu; Dermot P B McGovern; Kyuyoung Song
Journal:  Inflamm Bowel Dis       Date:  2015-01       Impact factor: 5.325

9.  Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.

Authors:  Garland Castaneda; Benny Liu; Sharon Torres; Taft Bhuket; Robert J Wong
Journal:  Dig Dis Sci       Date:  2017-08-30       Impact factor: 3.199

10.  Long-Term Outcomes of Infliximab Treatment in 582 Korean Patients with Crohn's Disease: A Hospital-Based Cohort Study.

Authors:  Sang Hyoung Park; Sung Wook Hwang; Min Seob Kwak; Wan Soo Kim; Jeong-Mi Lee; Ho-Su Lee; Dong-Hoon Yang; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Yong Sik Yoon; Chang Sik Yu; Jin-Ho Kim; Suk-Kyun Yang
Journal:  Dig Dis Sci       Date:  2016-03-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.